key: cord-0901432-ea530rz6
authors: Omame, Andrew; Abbas, Mujahid; Onyenegecha, Chibueze P.
title: Backward bifurcation and optimal control in a co-infection model for SARS-CoV-2 and ZIKV
date: 2022-04-09
journal: Results Phys
DOI: 10.1016/j.rinp.2022.105481
sha: 054c98fb242a6220408afe6496248b85207eed14
doc_id: 901432
cord_uid: ea530rz6

In co-infection models for two diseases, it is mostly claimed that, the dynamical behavior of the sub-models usually predict or drive the behavior of the complete models. However, under a certain assumption such as, allowing incident co-infection with both diseases, we have a different observation. In this paper, a new mathematical model for SARS-CoV-2 and Zika co-dynamics is presented which incorporates incident co-infection by susceptible individuals. It is worth mentioning that the assumption is missing in many existing co-infection models. We shall discuss the impact of this assumption on the dynamics of a co-infection model. The model also captures sexual transmission of Zika virus. The positivity and boundedness of solution of the proposed model are studied, in addition to the local asymptotic stability analysis. The model is shown to exhibit backward bifurcation caused by the disease-induced death rates and parameters associated with susceptibility to a second infection by those singly infected. Using Lyapunov functions, the disease free and endemic equilibria are shown to be globally asymptotically stable for [Formula: see text] , respectively. To manage the co-circulation of both infections effectively, under an endemic setting, time dependent controls in the form of SARS-CoV-2, Zika and co-infection prevention strategies are incorporated into the model. The simulations show that SARS-CoV-2 prevention could greatly reduce the burden of co-infections with Zika. Furthermore, it is also shown that prevention controls for Zika can significantly decrease the burden of co-infections with SARS-CoV-2.

At any time t, the total human population N h (t) consists of the following epidemiological states: Susceptible humans S h (t), infectious humans with SARS-CoV-2 K h C (t), infectious humans with Zika virus K h Z (t), humans co-infected with SARS-CoV-2 and zika virus K h CZ (t), with R(t), K h Z (t) denotes infected population recovered from SARS-CoV-2 and zika virus, respectively. The total vector population, at any time t, N v (t) consists of the following states: S v (t), K v Z (t), denoting susceptible vectors and vectors infected with Zika virus, respectively. Susceptible humans catch SARS-CoV-2 at the rate β1K h C Nh . Individuals in this state may catch zika virus either from infected humans or vectors at the rate

, respectively. Furthermore, since concurrent infection with both diseases is possible, we have assumed that susceptible individuals can get co-infected with SARS-CoV-2 and zika virus at the rate β3K h CZ Nh . Human-human-transmission of Zika has been investigated in the literature (see, for example [38] ). It is also assumed that the natural death rate for each epidemiological group is µ h . Infected individuals with SARS-CoV-2 can get infected with zika virus at the rate,

. Likewise, those infected with zika virus can get infected with SARS-CoV-2 at the rate α 2 β1K h C Nh . The death rates due to SARS-CoV-2, zika or co-infection are given by η C , η Z and η CZ , respectively. Moreover, recovery rates from SARS-CoV-2, zika virus or co-infection are denoted by ζ C , ζ Z and ζ CZ , respectively. In this model, we have assumed that no reversion or re-infection after recovery either from single or dual infections. Incorporating re-infection could be an extension to the proposed model. 

Value References η C SARS-CoV-2 disease-induced death rate 0.015 /day [37] η Z Zika disease-induced death rate, respectively 0.001 [39] Modification parameters 1.0 Assumed Table 1 : Description of parameters in the model (1) .

3 Analysis of the model

We shall now analyze the model qualitatively (1) without considering the controls. We begin with the following:

For the model (1) to be epidemiologically meaningful, it is appropriate to show that all its state variables are non-negative over time. We prove the results below:

, of the model (1) are non-negative for all time t > 0.

Proof: See Appendix A.

We claim the following result: 

Adding all the equations corresponding to the human components of the system (1), we have

It follows from (2) that

which can be re-written as

By applying the comparison theorem [32] and simplifying, we obtain that

Therefore, the total human population, N h (t) ≤ Λh µh as t → ∞. Following the arguments similar to those given above, the total vector population, N v (t) ≤ Λv µv . Hence, the system (1) has the solution in Q. Thus, the given system is positively invariant.

By setting the right-hand sides of the equations in the model (1) to zero, we obtain the disease free equilibrium (DFE) as follows:

The stability of the DFE is studied by applying the next generation operator method [33] to the system (1). The transfer matrices are given by

where,

The basic reproduction number of the model (1) is given by

where R 0C , R 0Z and R 0CZ are the associated reproduction numbers for SARS-CoV-2, Zika and co-infection of both diseases, respectively and are given by

For the sake of simplicity, reproduction number associated with the human-to-human Zika transmission is denoted by R h 0Z = β2 G2 , and the reproduction number associated with the vector-to-human-to-vector Zika transmission denotes

. Thus, the Zika associated reproduction number can be re-written as

3.3 Local asymptotic stability of the disease free equilibrium (DFE) of the model 

The local stability of the model (1) is analyzed by the Jacobian matrix of the system (1) evaluated at the disease-free J o u r n a l P r e -p r o o f Journal Pre-proof equilibrium, H 0 and is given by

The eigenvalues are given by

whereas, the remaining eigenvalues are the solutions of the equations given by

Applying the Routh Hurwitz criterion, the roots of equations in (8) have negative real parts if and only if R 0C < 1 and R 0Z < 1. Thus, the DFE, H 0 is locally asymptotically stable if R 0 = max{R 0C , R 0Z , R 0CZ } < 1.

Suppose the reproduction number R 0 = max{R 0C , R 0Z , R 0CZ } > 1. Also, let the factors playing a significant role in the disease transmission for the proposed model at steady state be denoted by:

Then the model (1) will have multiple endemic equilibria

In this section, we shall examine the impact of the assumption of allowing incident co-infection with both diseases (β 3 = 0) with the help of backward bifurcation analysis. The phenomenon of backward bifurcation, which has been observed in several disease models, is usually characterized by the co-existence of a stable disease free equilibrium and a stable endemic equilibrium when the associated reproduction number of the model is less than unity. The public health implication of the backward bifurcation phenomenon of model (1) is that, the classical epidemiological requirement of having the reproduction number R 0 less than unity, although necessary, is no longer sufficient for the effective control of the diseases. The following result is obtained using the approach in [41] .

To carry out the analysis, we set the disease induced death rates equal to zero because the disease-induce death rates give rise to backward bifurcation in a vector-host model (see for example, [39] ). Note that, the sub-model for SARS-CoV-2 does not undergo backward bifurcation, as already shown by the authors in [28] . Furthermore, some researchers on co-infection models (without the assumption of incident co-infection by susceptible individuals) [28] [29] [30] are of the view that the dynamical behavior of the sub-models usually predict the behavior of the complete co-infection models. This motivates the analysis in this paper, under the assumption of incident co-infection with both diseases. Setting the disease induced death rates η C = η Z = η CZ = 0, results in a constant population model, where, N h = Λh

Λh . The resulting model with bilinear incidence rates is thus presented in (11) . We are interested to investigate the question that if backward bifurcation occurs or not under this situation. If it does not occur, then the disease induced death will be the actual cause and the dynamics of the sub-model surely influences the complete model. However, if it occurs, we need to determine the parameter(s) which cause(s) such J o u r n a l P r e -p r o o f Journal Pre-proof occurrence in addition to disease induced death rate in the co-infection model.

The model (1) with negligible induced death rates η C = η Z = η CZ = 0, exhibits backward bifurcation if the coefficient a given below

denote an arbitrary endemic equilibrium of the model. By the following change of variables, (1) can be re-presented in the following form

Consider the case when R 0 = max{R 0C , R 0Z , R 0CZ } = 1. If the contact rate β 3 (say) is chosen as a bifurcation parameter, then solving for β 3 = β * 3 from R 0 = 1 we have β 3 = β * 3 = G 3 Similarly, for R 0 = max{R 0C , R 0Z , R 0CZ } = 1, we have β 3 = G 3 . Evaluating the Jacobian of the system (11) at the DFE, J(H 0 ), we obtain:

Using the approach in [41] , the matrix J(H 0 ) has a right eigenvector associated with the zero eigenvalue of J(H 0 ) given by ϕ = [ϕ 1 , ϕ 2 , ϕ 3 , . . . , ϕ 7 ] T , where the components are:

The non-zero components of the left eigenvector of J(H 0 )| β3=β * 3 , δ = [δ 1 , δ 2 , ..., δ 7 ] satisfying ϕ.δ = 1 are

Using Theorem 4.1 in [41] and computing the non-zero partial derivatives of f (x) at the disease free equilibrium, (H 0 )), the associated bifurcation coefficients are defined below

It clearly shows that even under the assumption that the disease induced death rates are zero, the bifurcation coefficients a and b are positive which indicates the occurrence of backward bifurcation. However, if we set the parameters associated with the susceptibility to infection with a second disease by individuals infected with single infection α 1 = α 2 = 0, then the co-efficient satisfies

which rules out the possibility of backward bifurcation in the co-infection model. Thus, it is concluded that, human disease-induced death rates and terms associated with susceptibility to additional infection by singly infected individuals can induce backward bifurcation in the co-infection model for two diseases. Therefore, it is observed that, in addition to disease induced death rates (which induced bifurcation in the sub-model), parameters associated with infection with a second disease cause backward bifurcation in the complete model. Hence, by allowing incident co-infection with both diseases, the dynamics of the sub-model does not always drive or influence the dynamics of the complete co-infection model.

Global asymptotic stability of the disease-free equilibrium of the model (1) for a special case Theorem 3.5 In the absence of infection with a second disease by singly infected individuals (that is, α 1 = α 2 = 0), the DFE of the model (1) given by Q 0 , is GAS in Q provided that R 0 ≤ 1.

The epidemiological implication of the Theorem 3.5 is; if those already infected with a single disease do not get infected with a second disease, then both SARS-CoV-2 and Zika can be eliminated from the population provided that the threshold quantity, R 0 < 1, regardless of the initial sizes of the sub-populations.

3.7 Global asymptotic stability of endemic equilibrium of the model (1) for a special case Theorem 3.6 In the absence of infection with a second disease by singly infected individuals (that is,

The epidemiological significance of Theorem 3.6 is; if those already infected with a single infection do not get infected with a second disease, and if diseases induced death is negligible, then both SARS-CoV-2 and HBV will persist in the population provided that the threshold quantity,R 0 > 1.

It was observed in the preceding sections that the occurrence of backward bifurcation in the model (1) makes the effective control of both diseases difficult in the population. The aim of this section is to incorporate the time dependent controls into the model (1) to obtain the optimal interventions for the elimination of the co-infections. They are defined as follows: θ 1 (t): SARS-CoV-2 prevention control, θ 2 (t): Zika prevention control, θ 3 (t): Control against incident co-infection, and J o u r n a l P r e -p r o o f Journal Pre-proof θ 4 (t): Control against infection with a second disease, and the optimal control model is given by:

subject to the initial conditions

Let us consider the following objective function

where T is the final time. The total cost includes the cost of SARS-CoV-2 and arboviruses preventive measures. We need to find an optimal control θ *

where

. The Hamiltonian is given by:

We now establish the existence of solution for the optimal control that minimizes the objective functional J.

Theorem 4.1 Suppose J is defined on the control set U subject to system (15) with non-negative initial conditions at t = 0, then there exists an optimal control u * = (θ 1 ,

if the following conditions given in [44] hold:

(i.) The admissible control set U is convex and closed. (iii.) The integrand of the objective functional in (16) is convex with respect to the controls.

Proof:

x, θ) the right hand of (15) , that is,

To prove Theorem 4.1, we proceed as follows:

(i.) It is obvious to note that the U = [0, θ max ] 4 is closed. In addition, consider any two arbitrary elements v, w ∈ U ,

where

That is, λv + (1 − λ)w ∈ U , and hence U is a convex set.

(ii.) The control system (15) can be expressed as a linear function of control variables (θ 1 , θ 2 , θ 3 , θ 4 ) with the coefficients as functions of time and state variables:

As the parameters and variables of the model are positive, we have

(iii.) The optimal control problem's Lagrangian is given by

J o u r n a l P r e -p r o o f

Let us consider two arbitrary elements v, w ∈ U , with v = (v 1 , v 2 , v 3 , v 4 ), w = (w 1 , w 2 , w 3 , w 4 ). and λ ∈ [0, θ max ]. We now show that,

it follows from (20) that,

Taking the difference of the two equations given above, we have

Thus,

gives

and hence convexity of L.

(iv.) There exists constants 1 , 2 and 3 such that,

Hence,

Theorem 4.2 Suppose the set θ = {θ 1 , θ 2 , θ 3 , θ 4 } minimizes J over U , then adjoint variables 1 , 2 , ..., 7 , satisfy the adjoint equations

with (where the adjoint functions given in the Appendix D)

Furthermore,

Proof of Theorem 4.2 Considering U * = (θ * 1 , θ * 2 , θ * 3 , θ * 4 ) and the associated solutions [43] is applied to obtain the following:

On the interior of the set, where 0 < θ j < 1 ∀ (j = 1, . . . , 4), we have

Therefore,

J o u r n a l P r e -p r o o f Journal Pre-proof

In this section, simulations of the control system (15) are carried out. This is done with MATLAB using the forward backward sweep by Runge Kutta method. The quadratic cost functions 1 2 ω 1 θ 2 1 , 1 2 ω 2 θ 2 2 , 1 2 ω 3 θ 2 3 and 1 2 ω 4 θ 2 4 are used. The weight constants are assumed as: ω 1 = 25, ω 2 = 20, ω 3 = 35 and ω 4 = 45.

In the subsequent sections, we investigate the impact of various control strategies on the co-dynamics of both diseases and their co-infection. For the demographic parameters, Λ h and µ h , we obtained their values based on the total population and life expectancy of Espirito Santo state, Brazil (a country with co-endemicity of both SARS-CoV-2 and zika virus), which are approximately given by 4,108,508 and 74.9 respectively [46, 47]. The initial conditions used for the simulations are set as follows: S h (0) = 3, 600, 000; I h C (0) = 800; I h Z (0) = 24; I h CZ (0) = 100; R(0) = 100; S v (0) = 4000; I v Z (0) = 600. The simulations of the optimal control system (15) when the strategy that prevents SARS-CoV-2 (θ 1 = 0) is implemented, are depicted in Figures 1a and 1b , respectively. On implementation of this intervention strategy, for β 1 = 0.2441, β 2 = 0.02441, β h 2 = 0.200, β 3 = 0.18, β v 2 = 0.501, so that R 0 = max{R 0C , R 0Z , R 0CZ } = 1.1938 > 1, we observe a significant decrease in the total number of individuals infected with SARS-CoV-2, as expected (shown in Figure 1a ). Interestingly, this strategy has significant impact on co-infected cases. It is observed that, significant co-infected cases of SARS-CoV-2 and Zika are averted by this control strategy (as depicted in Figure 1b) . The control profile for this intervention strategy is depicted in Figure 1c , showing very high impact against incident infections either with SARS-CoV-2 or co-infections.

The simulations of the optimal control system (15) when the strategy that prevents Zika transmission (from both human and vectors) (θ 2 = 0) is implemented, are depicted in Figures 2a, 2b, 2c , respectively. Implementation of this intervention strategy, for β 1 = 0.2441, β 2 = 0.02441, β h 2 = 0.200, β 3 = 0.18, β v 2 = 0.501, so that R 0 = max{R 0C , R 0Z , R 0CZ } = 1.1938 > 1 shows a significant decrease in the total number of individuals infected with Zika virus, as expected (shown in Figure  2a) . Also, this strategy has high positive population level impact on co-infected cases, as observed in Figure 2b . It is interesting to note that zika prevention strategy averts more co-infection cases than the SARS-prevention strategy. Equally, this strategy caused great reduction in infected vector populations as observed in Figure 2c . The control profiles for this strategy are depicted by Figure 2d . It is observed that the control has very high effect against Zika transmission. 

The simulations of system (15) when the strategy that prevents incident co-infection with SARS-CoV-2 and Zika virus (θ 3 = 0) is implemented, are depicted in Figures 3a and 3b . Implementation of this intervention strategy, for Figure  3a . Thus, to avert co-infection cases in the population, it is not enough to prevent new single cases. Efforts must also be made to prevent individuals from getting infected with concurrent infections. This control strategy also caused a great reduction of infected vector population, as shown in Figure 3b . Also, the simulation of the system (15) when the strategy that prevents infection with a second disease by those already infected, is depicted by Figure 3c . It is observed that a good number of co-infected cases is averted when this strategy is strictly put in place. The control profiles for prevention of incident co-infections and prevention of an additional infection by singly infected individuals, are presented in Figures 3d  and 3e . It is observed that, the control strategy against incident co-infections attains its peak value nearly after 50 days into the simulation period and throughout maintains this value. Moreover, the control against infection with a second disease, was at its peak throughout the simulation period. 

Journal Pre-proof 6 Conclusion In this paper, a new mathematical model for SARS-CoV-2 and Zika co-dynamics was presented, incorporating incident co-infection by susceptible individuals which is not common in the existing models. We discussed the impact of this assumption on the dynamics of a co-infection model. The model also incorporated sexual transmission of Zika. The positivity and boundedness of solution of the developed model was investigated, in addition to local asymptotic stability analysis. The model was shown to exhibit backward bifurcation, caused by disease induced death rates and parameters associated with susceptibility to a second infection by those already infected. Employing the Lyapunov functions, the disease free and endemic equilibria were shown to be globally asymptotically stable for R 0 < 1 and R 0 > 1, respectively. To manage the co-circulation of both infections in an effective manner, under an endemic setting, time dependent controls in the form of SARS-CoV-2, Zika and co-infection prevention strategies were incorporated into the model. The simulations showed that SARS-CoV-2 prevention could greatly reduce the burden of co-infections with Zika. Furthermore, it was shown that prevention controls for Zika can significantly reduce the burden of co-infections with SARS-CoV-2. We expect that the findings of this paper will open new avenues of research in this direction.

The model proposed in this paper focused only on SARS-CoV-2 and Zika co-infection, without vaccination or reinfection either with single or both diseases. Incorporating vaccination for SARS-CoV-2 and re-infection for both diseases, one could obtain an extension of the model. Also, the emergence of different variants of SARS-CoV-2 attracts further studies on their co-infections with other diseases, such as Zika, dengue, TB, influenza, Malaria and others. One could therefore, consider multi-strains of SARS-CoV-2 and co-infection with zika virus. Also, more investigations could be carried out to the mathematical (stochastic, agent based modelling, within/intra-host) and epidemiological dynamics of SARS-CoV-2 and Zika co-infection. The current research was not a case study because of insufficient data and information about the co-infection of both diseases. For instance, little is known about infection acquired cross-immunity between both diseases. Not much information is available to answer the question: whether the current available vaccines against SARS-CoV-2 could have any impact on the dynamics of zika virus. Thus, further studies with more reliable data and detailed information about the co-infection of both diseases is viable.

Authors are thankful to the reviewers and managing editor for their constructive comments and useful remarks which helped us a lot to improve the presentation and quality of the manuscript.

Appendix A: Proof of Theorem 3.1

Nh , then the first model equation can be written as:

Applying the integrating factor method on (29), we obtain

Similarly, it can be shown that:

Appendix B: Proof of Theorem 3.5

Consider the Lyapunov function

with Lyapunov derivativė

which can be further simplified intȯ

Since all the model parameters and variables are non-negative, it follows thatL 1 < 0 for R 0 = max{R 0C , R 0Z , R 0CZ } ≤ 1. Hence, L 1 is a Lyapunov function on Q. Thus, the DFE is globally asymptotically stable [34] .

Appendix C: Proof of Theorem 3.6

Consider the model (1) 

Λh ) and R 0 > 1, so that the associated unique endemic equilibrium exists. Also, consider the non-linear Lyapunov function: 

From model (1) at steady state, we have

Substituting the expressions in (32) into (31) giveṡ

which after some algebraic manipulations is reduced tȯ

The above can be simplified tȯ

As arithmetic mean is greater that geometric mean, the following inequalities from (34) hold:

Thus,L 2 ≤ 0 forR 0 > 1. Hence, L 2 is a Lyapunov function in D D 0 and we conclude that the GAS of EEP is globally asymptotically stable forR 0 > 1. 

Impact of concurrent epidemics of dengue, chikungunya, zika, and COVID-19

Arboviral diseases and COVID-19 in Brazil: Concerns regarding climatic, sanitation, and endemic scenario

Semanas Epidemiológicas 01 a 52

Preventing dengue epidemics during the COVID-19 pandemic

Concerns about COVID-19 and arboviral (chikungunya, dengue, zika) concurrent outbreaks

Impact of information intervention on stochastic hepatitis B model and its variableorder fractional network

Development and Analysis of A Seir Model for Covid-19 Epidemic with Vaccination and Nonsingular Kernel

Numerical and theoretical analysis of Rabies model under the harmonic mean type incidence rate

Fractional time-delay mathematical modeling of Oncolytic Virotherapy

A fractional-order multi-vaccination model for COVID-19 with non-singular kernel

Stochastic model and simulation of the prevalence of measles

Analysis of a stochastic mathematical model for tuberculosis with case detection

Modelling the spread of COVID-19 with new fractal-fractional operators: can the lockdown save mankind before vaccination?

The dynamics of COVID-19 with quarantine and isolation

Nonlinear growth and mathematical modelling of COVID-19 in some African countries with the Atangana-Baleanu fractional

Fractional Optimal Control Dynamics of Coronavirus Model with Mittag-Leffler Law

Stability analysis and optimal control of COVID-19 with quarantine and media awareness

COVID-19 and dengue co-infection in Brazil: optimal control and cost-effectiveness analysis

A fractional order model for Dual Variants of COVID-19 and HIV co-infection via Atangana-Baleanu derivative

Analysis of COVID-19 and comorbidity co-infection Model

Investigation of interactions between COVID-19 and diabetes with hereditary traits using real data: A case study in Turkey

A fractional-order control model for Diabetes COVID-19 co-dynamics with Mittag-Leffler function

Bifurcation analysis of a discrete-time compartmental model for hypertensive or diabetic patients exposed to COVID-19

Optimal control analysis of a COVID-19 and Tuberculosis Co-dynamics Model

A fractional-order model for COVID-19 and Tuberculosis Co-infection using Atangana-Baleanu derivative

Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in africa: a geospatial modelling analysis

The potential public health consequences of COVID-19 on malaria in Africa

Malaria and COVID-19 co-dynamics: A mathematical model and optimal control

A mathematical analysis of malaria and tuberculosis co-dynamics

Mathematical analysis of the transmission dynamics of HIV syphilis Co-infection in the presence of treatment for syphilis

Monitoramento Dos Casos de Arboviroses Urbanas Transmitidas Pelo Aedes Aegypti (Dengue

Stability Analysis of Nonlinear Systems

Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission

The Stability of Dynamical Systems

Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility

A mathematical model for simulating the phase-based transmissibility of a novel coronavirus

Impact of Non-Pharmaceutical Interventions (NPIs) to Reduce COVID-19 Mortality and Healthcare Demand

The "unholy" Chikungunya-Dengue-Zika Trinity: A Theoretical Analysis

Backward bifurcations in Dengue transmission dynamics

A conceptual model for the coronavirus disease 2019 (COVID-19) outbreak in Wuhan, China with individual reaction and governmental action

Dynamical models of tuberculosis and their applications

Sensitivity and uncertainty analysis of complex models of disease transmission: an HIV model, as an example, Int

The mathematical theory of optimal control process 4

Deterministic and Stochastic Optimal Control

Principles of optimization theory